Consistent with this, increasing the expression of FOXM1 in human cancer cells increased their tumorigenicity in xenograft models, while RNAi-mediated knockdown of FOXM1 decreased cancer cell proliferation and suppressed tumor growth in nude mice [51]. The gene discussed is FOXM1; the disease is cancer.